Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases

Tigecycline has been used to treat patients with febrile neutropenia (FN). This study aims to analyse the effectiveness of tigecycline as salvage treatment of FN. Patients records from 09/2004 to 04/2019 were reviewed. Cases were eligible if fever persisted/recurred (p/r-FN) after 3 days of second-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Geßner, Daniel, Berisha, Mirjeta, Esser, Torben, Schalk, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444688/
https://www.ncbi.nlm.nih.gov/pubmed/37186157
http://dx.doi.org/10.1007/s00277-023-05222-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444688/
https://www.ncbi.nlm.nih.gov/pubmed/37186157
http://dx.doi.org/10.1007/s00277-023-05222-5

Ejemplares similares